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Bordetella bronchiseptica mutants BRM1, BRM6, and BRM9 fail to produce the native dihydroxamate
siderophore alcaligin. A 4.5-kb BamHI-SmaI Bordetella pertussis genomic DNA fragment carried multiple genes
required to restore alcaligin production to these siderophore-deficient mutants. Phenotypic complementation
analysis using subclones of the 4.5-kb genomic region demonstrated that the closely linked BRM1 and BRM9
mutations were genetically separable from the BRM6 mutation, and both insertions exerted strong polar effects
on expression of the downstream gene defined by the BRM6 mutation, suggesting a polycistronic transcrip-
tional organization of these alcaligin biosynthesis genes. Subcloning and complementation experiments local-
ized the putative Bordetella promoter to a 0.7-kb BamHI-SphI subregion of the cloned genomic DNA fragment.
Nucleotide sequencing, phenotypic analysis of mutants, and protein expression by the 4.5-kb DNA fragment in
Escherichia coli suggested the presence of three alcaligin system genes, namely, alcA, alcB, and alcC. The
deduced protein products of alcA, alcB, and alcC have significant primary amino acid sequence similarities with
known microbial siderophore biosynthesis enzymes. Primer extension analysis mapped the transcriptional
start site of the putative alcaligin biosynthesis operon containing alcABC to a promoter region overlapping a
proposed Fur repressor-binding site and demonstrated iron regulation at the transcriptional level.
Iron is a fundamental nutritional requirement for virtually
all cells, and its assimilation is considered essential for invading
pathogenic bacteria to establish infection in the iron-limiting
environment of the host (13, 56). Additionally, iron serves as
an environmental modulator of the production of certain vir-
ulence factors in a number of bacteria (14, 24, 31, 32, 46).
Despite host iron sequestration, mediated primarily by the
glycoprotein family of iron-binding transferrins, pathogens
multiply successfully in vivo because they express efficient iron-
scavenging systems in response to decreased iron availability.
These iron retrieval systems utilize two general strategies: one
involving high-affinity iron-chelating soluble siderophores (30,
40) and the other using siderophore-independent cell surface
receptor mechanisms allowing iron uptake directly from host
sources such as transferrin, lactoferrin, and heme compounds
(7, 35, 38, 54).
Bordetella pertussis, the causative agent of human whooping
cough or pertussis, and Bordetella bronchiseptica, the agent of
swine atrophic rhinitis and kennel cough in dogs, are bacterial
pathogens that infect the respiratory epithelial mucosae of
their hosts. Early reports described the production of putative
siderophores by both B. pertussis and B. bronchiseptica in re-
sponse to iron deficiency (1, 23). Armstrong and Clements
isolated and characterized B. bronchiseptica transposon-in-
duced siderophore-deficient mutants; DNA hybridization stud-
ies using sequences flanking those transposon insertions con-
firmed the existence of homologs of B. bronchiseptica
siderophore system genes in B. pertussis (6). The siderophores
of B. pertussis and B. bronchiseptica have been characterized
structurally, and each has been identified as the macrocyclic
dihydroxamate siderophore known as alcaligin (11, 37), previ-
ously isolated from the taxonomically related bacterial species
Alcaligenes denitrificans subsp. xylosoxydans (41, 42). Charac-
terization of B. bronchisepticamanganese-resistant mutants ex-
hibiting deregulated expression of alcaligin and iron-repressed
proteins and restoration of iron repressibility by the B. pertussis
fur gene confirmed the role of the Fur repressor in regulation
of these traits in both Bordetella species (9).
B. bronchiseptica siderophore mutants generated in an ear-
lier study (6) were placed into distinct siderophore phenotypic
complementation groups on the basis of cross-feeding assays,
suggesting that multiple genes are involved in alcaligin biosyn-
thesis. The B. pertussis alcaligin biosynthesis gene odc, defined
by the mutation of B. bronchiseptica group III siderophore
mutant BRM3, was shown to encode an ornithine decarboxyl-
ase activity which catalyzes the conversion of ornithine to pu-
trescine, a required precursor of alcaligin in these species (10).
In this study, we have isolated alcaligin biosynthesis genes of
B. pertussis which functionally restored alcaligin production to
B. bronchiseptica siderophore mutants belonging to phenotypic
complementation group I. Our results identify an iron-regu-
lated polycistronic alcaligin biosynthesis gene cluster in Borde-
tella spp. predicted to encode proteins with primary amino acid
sequence similarity to biosynthetic enzymes of other sid-
erophore systems.
MATERIALS AND METHODS
Bacterial strains and plasmids. Wild-type strain B. bronchiseptica B013N, B.
bronchiseptica alcaligin biosynthetic mutants BRM1, BRM6, and BRM9 (6), and
wild-type B. pertussis UT25 (19) have been described previously. Escherichia coli
DH5a (Bethesda Research Laboratories, Gaithersburg, Md.) and DH10B (Be-
thesda Research Laboratories) were used as hosts for general DNA manipula-
tions. E. coli HB101 harboring pRK2013 (20) was used to provide mobilization
functions in conjugations. E. coli K38(pGP1-2) (53) was used for T7 promoter-
directed conditional protein expression experiments. Plasmid vectors pGEM3Z
(Promega, Madison, Wis.), pBluescript SK1 (Stratagene, La Jolla, Calif.),
pBBR1MCS (29), and pRK415 (28) were used for the construction of recombi-
nant plasmids. The cosmid pCP13-based gene library of B. pertussis UT25 has
been described (12). Plasmids pBRM1, pBRM6, and pBRM9 contain the cloned
mini-Tn5 lacZ1 chromosomal insertions of mutants BRM1, BRM6, and BRM9,
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respectively, along with flanking genomic sequences (6). Plasmid pBRM1 was
used as the source of B. bronchiseptica chromosomal DNA for probes in DNA
hybridization experiments.
Growth conditions. B. bronchiseptica B013N and siderophore biosynthesis
mutants were grown in parallel in iron-replete or iron-depleted Stainer Scholte
(SS) liquid medium (47, 49) as described previously (6). Optical densities of SS
cultures were monitored with a Klett-Summerson colorimeter fitted with a no. 54
filter (Klett Mfg. Co., Long Island City, N.Y.). B. bronchiseptica and B. pertussis
were cultured on blood agar and Bordet-Gengou (8, 19) agar, respectively; E. coli
was grown on Luria-Bertani medium (36). When required, the following antibi-
otics were added to culture media at the indicated concentrations: ampicillin
(100 mg/ml), chloramphenicol (30 mg/ml), gentamicin (10 mg/ml), kanamycin (50
mg/ml), nalidixic acid (35 mg/ml), streptomycin (50 mg/ml), and tetracycline (15
mg/ml).
Siderophore detection. Chrome azurol S (CAS) agar for assessment of B.
bronchiseptica alcaligin production was prepared as described earlier (6). The
CAS universal siderophore detection assay (48) was used to monitor siderophore
production by Bordetella cells grown in iron-depleted SS by measuring the de-
crease in A630 of the CAS dye reaction as reported previously (6).
General DNA techniques. Conjugal transfer of plasmids from E. coli to Bor-
detella spp. was by triparental mating as described previously (10). General
genetic techniques were performed as described in the procedures of Sambrook
et al. (43). Nucleotide sequencing using double-stranded plasmid templates was
performed by the dideoxy chain termination method (44) as modified by De-
Shazer et al. (18) with [32P]dATP (ICN Radiochemicals, Irvine, Calif.) and a
Sequenase version 2.0 kit (United States Biochemical Corp., Cleveland, Ohio).
The nucleotide sequence of the alcABC promoter-operator region was deter-
mined for both DNA strands, while analyses of the predicted products of alcB
and alcC were based on the nucleotide sequence from one strand. Nucleotide
sequence data management and analysis used DNA Strider 1.2 software (Service
de Biochimie et de Ge´ne´tique Mole´culaire, Gif-Sur-Yvette, France) for the
Macintosh computer. Database searches and data retrievals were done with the
BLAST (3) and RETRIEVE electronic mail servers developed by the National
Center for Biotechnology Information at the National Library of Medicine. For
protein database BLASTP searches, Bordetella DNA sequences were translated
in all six possible reading frames, and the resulting amino acid sequences were
transmitted to the National Center for Biotechnology Information for analysis
with the nonredundant database mandatory DATALIB search parameter. All
other search parameters were BLAST default values. Multiple amino acid se-
quence alignments were performed by the J. Hein method (26) with the
MegAlign module of a demonstration version of the Lasergene sequence analysis
software system for the Macintosh PowerPC computer (DNASTAR, Inc., Mad-
ison, Wis.). DotPlot comparisons used to identify putative Fur-binding sequences
were also performed with the MegAlign module of the Lasergene sequence
analysis software system for the Macintosh PowerPC computer, with search
parameters programmed to identify Bordetella DNA regions of at least 50%
identity over a 30-nucleotide search window with the dyad sequence 59-GATA
ATGATAATCATTATC-39.
Southern and in situ DNA hybridizations were performed at high stringency as
described previously (43). Hybridization probes derived from a 2-kb NotI-EcoRI
B. bronchiseptica DNA fragment of pBRM1 were labelled with [32P]dCTP (ICN
Radiochemicals) by the random priming method with the Prime-a-Gene labeling
system (Promega).
RNA isolation. RNA was isolated by a modification of the acid guanidinium
thiocyanate-phenol-chloroform extraction method of Chomczynski and Sacchi
(15). Solutions used in RNA isolation were treated with 0.1% diethylpyrocar-
bonate whenever possible. B. pertussis UT25 was streaked from frozen stocks
onto Bordet-Gengou agar plates and cultured at 378C for 30 to 48 h, at which
time plate growth was used to inoculate iron-replete SS broth seed cultures. Seed
cultures were grown for 30 to 48 h at 378C with shaking, harvested, washed twice
with iron-depleted SS, and used to inoculate 50 ml of iron-replete or iron-
depleted SS to an initial density of 30 Klett units. Cultures were grown at 378C
with shaking until the mid-logarithmic growth phase, reaching densities of 175 to
225 Klett units after 16 to 24 h.
To prepare approximately 50 ml of guanidine thiocyanate (GdSCN) lysis
solution for Bordetella RNA isolation, 23.6 g of solid GdSCN was dissolved in 28
ml of H2O in a sterile bottle, to which was added 2.5 ml of 0.5 M sodium citrate
(pH 7.0), 1.25 ml of 20% N-lauroylsarcosine, and 0.36 ml of 2-mercaptoethanol.
Cells were pelleted by centrifugation at 48C, immediately resuspended in 5 ml of
GdSCN lysis solution, and lysed by vortexing. One milliliter of 2 M sodium
acetate (pH 4.0) was added to acidify the mixture, 5 ml of unbuffered H2O-
saturated phenol was added, and the mixture was vortexed vigorously. One
milliliter of CHCl3-isoamyl alcohol (49:1) was added and mixed well, and the
tubes were placed on ice for 15 min. The mixtures were centrifuged at 10,000 3
g at 48C for 10 min to separate the phases, the upper aqueous phase was
transferred to a fresh tube, and RNA was precipitated by the addition of an equal
volume of isopropanol and held overnight at 2208C. RNA was recovered by
centrifugation at 10,000 3 g at 48C for 15 min. The RNA pellets were drained,
briefly air dried, and redissolved in 0.7 ml of GdSCN lysis solution prior to
transfer to microcentrifuge tubes and the addition of an equal volume of iso-
propanol. After incubation at 2208C for at least 1 h, the RNA precipitate was
sedimented in a microcentrifuge at maximum speed for 15 min at 48C, and the
pellet was drained well and rinsed twice with 1-ml volumes of cold 70% ethanol.
The RNA was air dried, dissolved in H2O, and quantitated spectrophotometri-
cally. After quantitation, the RNA solution was divided among microcentrifuge
tubes to provide 50 mg of RNA per tube, which was precipitated by the addition
of 0.1 volume of 3 M sodium acetate (pH 5.2) plus 2.5 volumes of ethanol. RNA
was stored as a precipitate under ethanol at 2708C.
RNA transcript mapping by primer extension. Primer extension mapping was
performed as described previously (43), with 50 mg of total RNA and 100 fmol
of 32P-end-labelled oligonucleotide primer per reaction. RNA was denatured at
858C for 10 min and then hybridized with radiolabelled antisense primer over-
night at 428C. Extension reactions used 400 U of Moloney murine leukemia virus
reverse transcriptase (Bethesda Research Laboratories) at 378C. The 35-mer
oligonucleotide primer used to map the 59 terminus of the alc transcript (59-G
TGTCTGTCCCGTATGCCGCCTTGCCGAAGCACTG-39) was the antisense
of nucleotides 529 to 563 in Fig. 2 and was also used to generate the accompa-
nying DNA sequencing ladder from an alc plasmid template.
Cell fractionation and sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE). B. bronchiseptica cells harvested from both iron-replete
and iron-depleted SS cultures were resuspended in 10 mM N-2-hydroxyeth-
ylpiperazine-N9-2-ethanesulfonic acid (HEPES; pH 7.4) and disrupted with a
French pressure cell (American Instrument Company, Silver Spring, Md.). The
pressates were centrifuged at 2,3163 g for 5 min to sediment unbroken cells, and
the resulting supernatants were centrifuged at 132,300 3 g at 48C for 1 h to
obtain soluble and insoluble cell fractions.
For analysis of total cellular proteins, B. pertussis cells were harvested from
iron-replete and iron-depleted SS cultures and solubilized, and the proteins were
resolved by SDS-PAGE on 10% polyacrylamide gels containing 0.5 M urea (47).
Approximately 40 mg of protein was applied per lane. Proteins were visualized by
Coomassie blue staining.
Expression of plasmid-encoded proteins. Plasmid-encoded polypeptides were
radiolabelled with Tran35S-label (ICN Biochemicals, Inc., Irvine, Calif.) by use of
E. coli host strain K38(pGP1-2) and the T7 polymerase-promoter conditional
expression technique of Tabor and Richardson (53). The proteins were visual-
ized by autoradiography after fractionation by SDS-PAGE on 12% polyacryl-
amide gels.
Construction of B. pertussis alcB and alcC mutants. A kanamycin resistance
gene cassette isolated from plasmid pBSL86 (2) as a SphI fragment was ligated
into the SphI site internal to alcB on the 4.5-kb BamHI-SmaI B. pertussis DNA
fragment. The BamHI-EcoRI subfragment encompassing the mutated alcB re-
gion was then subcloned to the allelic exchange plasmid vector pSS1129 (50).
Two plasmids, carrying alcB interrupted by the kanamycin cassette in both
possible orientations with respect to alc transcription, were each conjugally
transferred to the streptomycin-resistant derivative of B. pertussis UT25,
UT25Sm1 (5, 10), and the mutations were transferred to the chromosome by
homologous recombination as described by Stibitz (50). Allelic exchange in each
mutant was verified by Southern hybridization analysis.
The internal 0.6-kb ClaI fragment of the B. pertussis alcC gene was deleted
from the 4.6-kb B. pertussis alcABC SmaI fragment by digestion with ClaI fol-
lowed by religation, and the remaining 4.0-kb region containing the mutation was
subcloned to the allelic exchange plasmid vector pRTP1 (50). The alcC deletion
mutation was transferred to the chromosome of B. pertussis UT25Sm1 by ho-
mologous recombination and confirmed by Southern hybridization analysis as
described for the alcB mutants.
Nucleotide sequence accession number. The GenBank accession number as-
signed to the nucleotide sequence of the B. pertussisUT25 alcABC control region
is U34894.
RESULTS
Identification of B. pertussis alcaligin biosynthesis genes by
restoration of siderophore production to B. bronchiseptica mu-
tants. A previous study identified and characterized B. bron-
chiseptica alcaligin biosynthesis mutants BRM1, BRM6, and
BRM9 assigned to phenotypic complementation group I on
the basis of cross-feeding assays (6). The genomic regions
containing the insertions of these mutants were cloned and
mapped; nucleotide sequencing primed from the transposon
ends of mini-Tn5 lacZ1 revealed that the sites of insertion
mutations defining BRM1 and BRM9 are separated by approx-
imately 200 bp (Fig. 1). Restriction mapping placed the BRM6
mutation approximately 1.4 kb from that of BRM9. To isolate
B. pertussis genes involved in alcaligin biosynthesis, a 2-kb
NotI-EcoRI B. bronchiseptica DNA fragment flanking the
transposon in mutant BRM1 was used as a source of hybrid-
ization probe DNA, resulting in the identification of 14 homol-
ogous recombinant cosmids representing five distinct overlap-
ping clones from our B. pertussis UT25 genomic library.
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Initially, these cosmids were conjugally transferred to the
group I mutant BRM9, and all were found to complement its
alcaligin biosynthetic defect. A 4.6-kb B. pertussis SmaI DNA
fragment shared by all of the recombinant cosmids was sub-
cloned from representative cosmid pCP1.11 and found to re-
store siderophore biosynthetic capability to all three group I
mutants (Fig. 1, plasmid pRK4).
Further subcloning, deletion, and complementation analysis
revealed that the minimal DNA region required to restore
alcaligin siderophore biosynthesis to mutants BRM1, BRM6,
and BRM9 was a 4.5-kb BamHI-SmaI subfragment (plasmid
pRK13). A smaller DNA fragment lacking the ClaI-SmaI re-
gion (pRK5) did not restore alcaligin production to any of the
group I mutants. Subclones lacking 59 DNA sequences (plas-
mids pRK6 through pRK10) complemented mutant BRM6 in
an orientation-dependent manner, suggesting that expression
of the complementing biosynthetic activity was driven from the
vector lac promoter; none of these plasmids conferred alcaligin
production to mutants BRM1 and BRM9. Furthermore, since
pRK6 and pRK8, but not pRK7, restored siderophore produc-
tion capability to BRM6, we hypothesized that the native Bor-
detella promoter likely resides in the 59 BamHI-SphI DNA
region, directing transcription of a distal gene encoding an
activity lacking in mutant BRM6. Plasmids pRK5, pRK11, and
pRK12 failed to restore alcaligin end product biosynthesis in
trans to BRM1 and BRM9, consistent with strong polarity
effects of the mini-Tn5 lacZ1 mutations on the downstream
gene defined by BRM6. Deletion derivative pRK11 comple-
mented the alcaligin defect of mutant BRM6 but not BRM1 or
BRM9, localizing DNA sequences predicted to encode the
biosynthetic functions affected in those two mutants. While
plasmid pRK10 restored alcaligin synthesis to BRM6, pRK12,
with an internal ClaI deletion, did not complement the sid-
erophore production defect of any group I mutant, suggesting
that the gene defining the BRM6 mutation resides on the
2.2-kb SphI-SmaI DNA subregion.
Insertion of a transcriptionally active kanamycin resistance
gene in either orientation into the right-most SphI site of the
4.5-kb BamHI-SmaI fragment resulted in the failure of that
cloned fragment to restore siderophore production to either
BRM1 or BRM9 (Fig. 1, plasmids pKmL and pKmR). How-
ever, alcaligin production by BRM6 carrying either pKmL or
pKmR was dependent on the transcriptional orientation of the
resistance cassette. That is, the insertion at SphI in pKmL was
strongly polar, whereas that in pKmR (transcribed in the same
proposed orientation as that of the alc genes) was not polar;
thus, pKmR could restore alcaligin biosynthesis to BRM6.
These data show that the BRM6 mutation is genetically
separable from those of BRM1 and BRM9 and are consistent
with the presence on pRK13 of at least two distinct alcaligin
biosynthesis genes cotranscribed from a Bordetella promoter
located within the 0.7-kb BamHI-SphI DNA region.
B. pertussis alcaligin-deficient mutants. Allelic exchange of
mutated alc DNA fragments from plasmids pKmL and pKmR
(Fig. 1) with wild-type alc alleles of B. pertussis UT25 resulted
in two B. pertussis mutants (PM-2 and PM-3, respectively),
both of which were unable to produce detectable levels of the
siderophore alcaligin. These results indicate that the genetic
region spanning that SphI restriction site is involved in alcaligin
synthesis.
Deletion of the internal ClaI DNA fragment from the al-
caligin genetic region (as shown for pRK12 in Fig. 1) followed
by allelic exchange in B. pertussis UT25 resulted in mutant
PM6-1, which also failed to produce detectable alcaligin.
Nucleotide sequence analysis of the 0.7-kb BamHI-SphI
DNA fragment required for expression of alc activities. Ge-
netic complementation analysis of BRM1, BRM6, and BRM9
with subclones of the 4.6-kb SmaI DNA fragment of B. pertus-
sis had determined that a terminal 0.7-kb BamHI-SphI subre-
gion was required for expression of alcaligin biosynthesis ac-
tivities affected in group I mutants. Nucleotide sequence
analysis of the BamHI-SphI DNA fragment (Fig. 2) revealed
the presence of sequences predicted to encode the N-terminal
47 amino acids of a B. pertussis homolog of oxygenase enzymes
involved in siderophore biosynthesis in other bacterial species.
The open reading frame beginning at nucleotide position 582
and extending through the SphI site exhibits 47% amino acid
sequence identity with E. coli L-lysine N6-hydroxylase IucD
involved in aerobactin siderophore biosynthesis (16, 27), 32%
identity with Pseudomonas aeruginosa L-ornithine N5-oxygen-
ase PvdA required for pyoverdin siderophore biosynthesis
(55), and 40% identity with Ustilago maydis L-ornithine N5-
oxygenase Sid1 involved in ferrichrome siderophore biosynthe-
sis (34). A study published while this manuscript was in review
reported the nucleotide sequence of the B. bronchiseptica alcA
gene (GenBank accession number U32117) and also noted the
similarity of the deduced protein product to these oxygenase
enzymes (22). Comparison of the nucleotide sequences from
the two Bordetella species revealed 99.4% identity over a
shared 349-bp region.
Seven nucleotides upstream from the predicted AUG start
codon is the Shine-Dalgarno-like sequence 59-AGGCGA-39,
which may direct initiation of AlcA translation. Further up-
stream, within an extensive region of unusually low G1C nu-
cleotide composition (34% versus the typical 66 to 70% for
Bordetella spp.) spanning nucleotide positions 380 to 490, are
two extensively overlapping 19-nucleotide sequences, 59-GAG
AATAGAAGTCATAATT-39 (positions 418 to 436) and 59-A
ATAGAAGTCATAATTATT-39 (positions 421 to 439), which
share 12 of 19 and 11 of 19 residues, respectively, with the
reported E. coli consensus Fur-binding site 59-GATAATGAT
AATCATTATC-39 (17, 52). Since these 19-nucleotide se-
quences overlap by 16 nucleotides, they likely represent a sin-
FIG. 1. Genetic complementation of group I B. bronchiseptica alcaligin bio-
synthesis mutants by cloned B. pertussis genomic DNA. The relative positions of
the insertional mutation sites of BRM1, BRM6, and BRM9 are shown as num-
bered triangles. Open arrowheads indicate the positions and orientations of the
vector lac promoter of the recombinant plasmids; delta symbols indicate deleted
sequences. Plasmids pKmL and pKmR each contain a kanamycin resistance gene
insertion at a SphI site; the direction of transcription of the kanamycin resistance
gene is indicated by the open flags. B. bronchiseptica alcaligin biosynthetic mu-
tants carrying the plasmids were evaluated for the ability (1) or inability (2) to
produce siderophore on CAS agar. Abbreviations: B, BamHI; C, ClaI; E, EcoRI;
P, PvuII; S, SmaI; Sp, SphI.
VOL. 178, 1996 BORDETELLA ALCALIGIN BIOSYNTHESIS GENES 4879
gle repressor-binding site. Because the most common
mechanism of transcription repression is interference with
RNA polymerase binding, we hypothesized that the B. pertussis
promoter directing alcA transcription was in the vicinity of
these predicted Fur-binding sequences. The identification of a
predicted rho-independent transcriptional terminator occupy-
ing nucleotide positions 193 to 221 further suggested that alcA
transcription originated between that terminator and the start
of the putative oxygenase open reading frame at nucleotide
position 582.
Mapping of transcriptional initiation sites for the alcA gene.
Expression of the alc operon is directed from a limited genetic
region bounded by the upstream BamHI restriction site and
the alcA coding sequences (Fig. 2). Sites of in vivo transcrip-
tion initiation from the alcA upstream region were localized by
primer extension analysis with total cellular RNA isolated
from B. pertussis UT25 grown under iron-replete or iron-de-
pleted conditions. Reverse transcription of mRNA primed by a
synthetic oligonucleotide representing the antisense of nucle-
otide positions 529 to 563 in Fig. 2 resulted in two products
(Fig. 3) corresponding to a primary transcription initiation site
(11) at the C residue at position 440 in Fig. 2, located 142
nucleotides upstream from the putative start of the alcA coding
region, and a less frequently utilized initiation site at the ad-
jacent T residue at position 441. Densitometric analysis of
autoradiographs indicated that approximately 60% of alc tran-
scripts originate at the primary site of initiation, whereas 40%
of alc transcripts start at the minor site. These sites are posi-
tioned near the 39 terminus of the B. pertussis sequences
strongly resembling the consensus E. coli Fur-binding site
spanning residue positions 418 to 439. The spatial organization
of the alc promoter region and the putative Fur-binding se-
quences suggest a promoter occlusion mechanism of transcrip-
tion repression. Densitometric analysis of extension product
signal intensities confirmed that steady-state alcA mRNA lev-
els are approximately 18-fold higher in the iron-depleted RNA
population than in the iron-replete RNA, suggesting that alcA
promoter activity is responsive to iron levels in the culture
medium.
Examination of sequences immediately upstream from the
11 sites revealed the presence of sequences with similarity to
E. coli s70 promoter determinants. The major alcA initiation
site is optimally spaced 7 nucleotides from the hexameric se-
quence AGTCAT, which shares 3 of the 6 most highly con-
served nucleotides with the E. coli s70 210 promoter consen-
sus sequence TATAAT (25), including the so-called invariant
T at the last position. Seventeen nucleotides upstream from
this Pribnow-like sequence is the sequence CGCACA, which
shares 3 of the 6 most highly favored nucleotides with the E.
coli s70 235 consensus sequence TTGACA (25). Other se-
quences resembling E. coli s70 promoter determinants exist,
although at suboptimal spacing intervals with respect to the
start sites. The major transcription initiation site is spaced only
4 nucleotides from the hexameric sequence CATAAT, which
more closely resembles the E. coli s70 210 consensus sequence
TATAAT, and 22 nucleotides upstream from this sequence is
the hexameric sequence TTCGCA, which contains 4 of the 6
most highly favored nucleotides shared among E. coli s70 235
promoter determinants. However, in the absence of genetic
evidence, the actual promoter sequences directing alcA tran-
scription are not known with certainty. The existing database
of Bordetella promoters is relatively small compared with that
of E. coli, and the most well-characterized Bordetella promot-
ers are dependent on the transcriptional activator BvgA (4,
51).
FIG. 2. Nucleotide sequence analysis of the 723-bp B. pertussis BamHI-SphI
fragment. The nucleotide sequence including the alcABC operon control region
and the N-terminal coding region of alcA is shown. The transcription initiation
sites (11) determined by primer extension analysis with the designated antisense
primer are underlined. Iron Box, sequences resembling an E. coli Fur-binding
site. The position of a Shine-Dalgarno-like sequence (SD) upstream from an
open reading frame (alcA) is indicated. The upstream position of a putative
transcription terminator is indicated by converging arrows.
FIG. 3. Promoter mapping by primer extension (PE). (Left) Extension prod-
ucts resulting from the use of the antisense primer shown in Fig. 2, identifying a
major transcription initiation site corresponding to the C residue at position 440,
and a less-abundant product corresponding to a start site at the adjacent T
residue at position 441. (Right) Overexposed autoradiograph demonstrating that
iron-depleted growth conditions (2) for B. pertussis results in an 18-fold increase
in steady-state levels of alcA-specific mRNA compared with that resulting from
iron-replete (1) growth conditions.
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The alcABC gene cluster. Nucleotide sequencing of a 2.6-kb
B. pertussis DNA region ranging from a position 170 bp up-
stream of the right-most PvuII site to the SmaI site of the
4.5-kb BamHI-SmaI fragment (data not shown) revealed the
presence of two open reading frames, designated alcB and
alcC. Figure 4 shows a genetic map of the proposed alcABC
gene cluster based also, in part, on the alcA nucleotide se-
quence of B. bronchiseptica (22). The deduced 53-kDa AlcA
protein of B. bronchiseptica has been reported to have 25%
identity and 61% similarity with E. coli IucD (22), a result
consistent with our analysis of the N-terminal coding region of
the predicted B. pertussis AlcA protein. Analyses of the B.
pertussis alcBC open reading frames, AlcB (23 kDa) and AlcC
(70 kDa), revealed strong primary amino acid sequence simi-
larities with enzymes IucB (GenBank accession number
X76100 [33]) and IucC (GenBank accession number X76100
[33]) involved in the biosynthesis of the E. coli siderophore
aerobactin. The B. pertussis deduced proteins AlcB and AlcC
demonstrated 23% identity (over a 167-amino-acid region)
with IucB and 28% identity (over a 563-amino-acid length)
with IucC, respectively. The compact genetic organization and
lack of canonical promoter sequences in alc intergenic regions,
along with observed polarity effects of insertion mutations, are
consistent with the existence of an operon transcribed from an
iron-responsive promoter-operator region upstream of alcA.
Analysis of proteins of Bordetella alcaligin biosynthesis mu-
tants. Initial SDS-PAGE experiments demonstrated that all
three group I B. bronchiseptica mutants lacked the iron-re-
pressed protein of 59 kDa, IR59 (9) (data not shown). Elec-
trophoretic analysis showed that in the wild-type, this protein
was in the soluble cell fraction, suggesting a cytoplasmic or
periplasmic cellular location (Fig. 5A). Expression of the 59-
kDa iron-repressed protein was restored to BRM1, BRM9,
and BRM6 by supplying alcaligin biosynthetic genes in trans as
plasmid pRK4. No other protein profile differences were ob-
served between wild-type strain B013N and mutants BRM1,
BRM9, and BRM6 in SDS-PAGE gels stained with Coomassie
blue. These data suggest that the mutation in BRM6 disrupts
the gene encoding IR59; BRM1 and BRM9 lack the protein as
a result of the polar influence of the transposon mutations on
this downstream gene. B. pertussis alcaligin mutant PM6-1,
with a 0.6-kb ClaI deletion in alcC, also appeared to lack
protein IR59 (Fig. 5B).
T7 promoter-directed protein expression. Protein expres-
sion directed by the 4.5-kb BamHI-SmaI B. pertussis DNA
fragment was examined by use of a bacteriophage T7 promoter
expression system in E. coli (Fig. 6). No significant levels of any
protein products were detected when the fragment was ori-
ented with the vector T7 promoter adjacent to the SmaI site.
However, when cloned in the opposite orientation, with the T7
promoter directing transcription in the same orientation as the
proposed native Bordetella promoter, the plasmid directed the
expression of multiple radiolabelled polypeptides ranging from
31 to 100 kDa. T7 plasmid 3 bears the same internal ClaI
deletion as B. pertussis alcaligin biosynthesis mutant PM6-1
and also failed to express a 59-kDa radiolabelled protein; plas-
mid 4, encompassing the DNA region complementing BRM6,
programmed the expression of the 59-kDa protein. Other ex-
periments confirmed that the 59-kDa protein observed in the
T7 expression experiments comigrated in electrophoretic gels
with authentic IR59 of B. bronchiseptica B013N (data not
shown). The T7 expression experiments produced a 51-kDa
labelled protein which may be the product of the alcA gene,
predicted to encode a protein of 53 kDa in B. bronchiseptica
(22). In multiple experiments, expression of other radiola-
belled species was consistent, although their presence did not
correlate with any specific alcABC subregions examined, sug-
gesting that the other observed products may represent arti-
facts of the E. coli expression system. The ca. 100-kDa doublet
was sporadically observed in other experiments with variety of
subclones (data not shown), suggesting that this polypeptide
may also be an artifactual translational product or perhaps T7
RNA polymerase itself (53).
The results of the protein expression analyses together with
the subcloning and complementation studies and nucleotide
sequencing indicate the presence of three alcaligin biosynthesis
genes (alcA, alcB, and alcC) on the 4.5-kb BamHI-SmaI DNA
fragment carried by pRK13, with the iron-repressed protein
IR59 encoded by the promoter-distal gene alcC.
FIG. 4. Genetic organization of alc system genes. The positions and orien-
tations of the alc genes and restriction enzyme cleavage sites are based on
nucleotide sequence data as described in the text. The mutation sites of BRM1,
BRM6, and BRM9 are shown as numbered triangles. Abbreviations: B, BamHI;
C, ClaI; E, EcoRI; P, PvuII; S, SmaI; Sp, SphI.
FIG. 5. SDS-PAGE analysis of B. bronchiseptica and B. pertussis alcaligin
mutants. (A) Soluble fractions of B. bronchiseptica cells were prepared and
subjected to electrophoresis as described in Materials and Methods. Lanes: 1,
wild-type B013N grown under iron-replete conditions; 2, B013N grown under
iron-depleted conditions; 3 to 8, soluble fractions of group I mutants carrying
plasmids and grown under iron-depleted conditions (3, BRM1/pRK415 [vector];
4, BRM1/pRK4; 5, BRM6/pRK415; 6, BRM6/pRK4; 7, BRM9/pRK415; 8,
BRM9/pRK4). Positions of molecular mass standards are shown in kilodaltons
on the left. (B) Total cellular proteins of B. pertussis wild-type strain UT25 and
alcC mutant PM6-1. Lanes: 1, UT25 grown under iron-replete conditions; 2,
UT25 grown under iron-depleted conditions; 3, PM6-1 grown under iron-replete
conditions; 4, PM6-1 grown under iron-depleted conditions. The position of the
59-kDa soluble protein is denoted by an arrow on the right in both panels.
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DISCUSSION
Both Alcaligenes and Bordetella spp., members of the Alcali-
genaceae, produce the macrocyclic siderophore alcaligin. B.
pertussis and B. bronchiseptica are considered genetically
closely related on the basis of nucleic acid hybridization and
multilocus enzyme electrophoresis analyses (39); correspond-
ingly, the DNA sequences of B. pertussis odc and the known
sequences for the B. bronchiseptica odc region revealed identity
at the nucleotide sequence level (10). As it was in our studies
of Bordetella odc (10) and fur (9), our strategy utilizing the
more readily cultured B. bronchiseptica for mutant construc-
tion to identify and isolate B. pertussis genes has proven to be
an effective approach to the study of siderophore-mediated
iron acquisition in B. pertussis. A 4.5-kb B. pertussis genomic
BamHI-SmaI DNA fragment was identified; this fragment
could restore alcaligin production to three B. bronchiseptica
mutants originally assigned to the same siderophore pheno-
typic complementation group. B. bronchiseptica mutants
BRM1 and BRM9 carry mini-Tn5 lacZ1 insertions which in-
activate the alcaligin biosynthesis gene alcA, while the BRM6
mutation is located in the genetically distinct alcC locus. B.
pertussis mutants constructed by allelic exchange, PM-2 and
PM-3, defined the gene alcB, while mutant PM6-1 is defective
in alcC function. Complementation analysis revealed strong
polarity of the transposon insertions of BRM1 and BRM9 on
downstream chromosomal gene expression, resulting in an al-
caligin-deficient phenotype which could not be complemented
by the alcA or alcAB region alone supplied in trans. Additional
polarity effects were observed in BRM1, BRM6, and BRM9 in
experiments using the kanamycin resistance gene insertions in
the 4.5-kb alcDNA fragment. All three B. bronchiseptica group
I mutants lacked a 59-kDa soluble iron-repressed protein
which was restored along with alcaligin production by the
4.6-kb SmaI alcDNA fragment. In T7 bacteriophage promoter
protein expression experiments, the alcC region directed the
expression of an approximately 59-kDa polypeptide, consistent
with the apparent molecular mass of the soluble protein lack-
ing in the B. bronchiseptica mutants as well as in B. pertussis
alcC mutant PM6-1.
Nucleotide sequencing of the 723-bp region encompassing
the 59 region of alcA revealed a putative rho-independent
terminator structure and an intergenic region bearing one or
two overlapping proposed Fur-binding sites and the start of an
open reading frame predicted to encode a protein with simi-
larity to oxygenases of other microbial hydroxamate sid-
erophore biosynthesis systems. The location of alcA is in agree-
ment with a recent report describing the alcA nucleotide
sequence of the related species B. bronchiseptica (22). The
nucleotide sequence of the B. bronchiseptica alcA gene is pre-
dicted to encode a 53-kDa protein with an N-terminal 47-
amino-acid sequence identical to that of the deduced B. per-
tussis AlcA protein described in this study.
Primer extension analysis of mRNA from B. pertussis grown
under iron-replete and iron-depleted conditions defined pri-
mary and secondary transcriptional start sites adjacent to the
proposed Fur-binding site and demonstrated iron regulation at
the transcriptional level. Studies in this laboratory are under
way to confirm the involvement of the proposed Fur-binding
sequences in the regulation of alcABC gene expression and to
determine the 39 limit of the transcript. A recent study de-
scribed Bvg-regulated alcaligin production in certain biotypes
of B. bronchiseptica (21). Although examination of the B. per-
tussis alcA upstream sequences reveals several potential BvgA-
binding sites (45), our studies indicate that alcaligin production
in the strains of B. bronchiseptica and B. pertussis used in this
study is not under BvgAS control but is regulated by iron
through the activity of the Fur repressor (9).
Nucleotide sequence analysis of the alcBC region of the
4.5-kb alc fragment revealed two additional open reading
frames predicted to encode proteins with similarity to biosyn-
thetic enzymes IucB and IucC of the E. coli aerobactin sid-
erophore system. These preliminary data, along with results of
genetic and phenotypic analyses of our B. bronchiseptica and B.
pertussis mutants, are consistent with the presence of three
alcaligin biosynthesis genes, alcA, alcB, and alcC, in a polycis-
tronic transcriptional organization. The sizes of the predicted
Alc proteins are as follows: AlcA, 53 kDa; AlcB, 23 kDa; AlcC,
70 kDa. The corresponding Iuc protein homologs, IucD (49
kDa), IucB (37 kDa), and IucC (67 kDa), possess the enzy-
matic activities L-lysine N6-hydroxylase and N6-hydroxylysine
acetyl-coenzyme AN6-transacetylase and an activity which par-
ticipates in the condensation of two molecules of N6-acetyl-N6-
hydroxylysine and citric acid, respectively (16). Despite appar-
ent similarities between the Alc and Iuc proteins, Giardina et
al. found that the B. bronchiseptica alcA gene did not comple-
ment an E. coli iucD mutant (22). This is not surprising, given
the obvious structural differences between alcaligin and aer-
obactin. Our protein analyses of B. bronchiseptica and B. per-
tussis mutants and T7 protein expression experiments consis-
tently identified IR59 as the protein encoded by alcC, although
the predicted polypeptide has a size of nearly 70 kDa. A la-
belled protein of 51 kDa observed in the T7 protein expression
FIG. 6. Proteins expressed from the 4.5-kb BamHI-SmaI B. pertussis DNA
fragment by use of a T7 RNA polymerase-promoter system in E. coli. (A)
Genetic limits of the cloned DNA fragments. Filled arrowheads represent the
orientation of the vector T7 promoter; the delta symbol denotes deletion of the
ClaI fragment. The T7 expression plasmid number is indicated on the left.
Restriction site abbreviations are identical to those described in the legend to
Fig. 1. (B) Autoradiogram of 35S-labelled translational products resolved by
SDS-PAGE. Lanes: V, vector pGEM3Z; 1 to 5, numbers correspond to the T7
plasmid numbers in panel A. Molecular mass standards (in kilodaltons) are
shown on the left. The strongly radiolabelled polypeptide of 59 kDa expressed
from the alcC region of the 4.5-kb BamHI-SmaI fragment is indicated on the
right.
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experiments has a size similar to that of the deduced AlcA
protein, but a polypeptide corresponding to the predicted 23-
kDa AlcB size was not detected in those studies.
Information based on our experimental data and compari-
son with other siderophore systems allows the prediction of a
hypothetical alcaligin biosynthetic pathway (Fig. 7). The initial
reaction (I) yields putrescine from ornithine by the activity of
Odc ornithine decarboxylase, characterized previously (10).
The odc gene does not map near alcABC, and its protein
activity is not iron repressible; hence, it is not likely to be a
dedicated step in alcaligin biosynthesis although it supplies an
essential precursor. We propose subsequent hydroxylation of
putrescine (II) by the AlcA oxygenase and an acylation step
(III) involving succinate, perhaps catalyzed by a homolog of
the aerobactin system enzyme IucB (potentially encoded by
alcB). Given the structure of alcaligin, we hypothesize the
involvement of an activity catalyzing the condensation of the
ring (IV) and yet another activity (V) resulting in hydroxyl
additions at positions 8 and 18 in the ring. The order of these
postulated steps is unknown at this time; alternative biosyn-
thetic schemes could be envisioned but are likely to require
similar numbers of enzymatic activities. Since microbial sid-
erophore biosynthesis genes are usually clustered on the chro-
mosome, the coding regions for the uncharacterized alcaligin
biosynthesis activities may be located near alcABC.
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